SeQuent to acquire 51% of Indo Phyto


SeQuent Scientific has announced that it will acquire a controlling stake in Indo Phyto Chemicals (IPC), a New Delhi-based pharmaceutical company that focuses on female healthcare.

Chemical_structure,_vitamin_DIPC has a portfolio of steroids and hormonal active pharmaceutical ingredients (APIs) along with a manufacturing base in Uttarakhand. The company has capabilities in fermentation and chemical synthesis, giving it the ability to produce APIs from the basic starting materials that are extracted from plants. IPC currently produces 14 APIs and has 20 more under development.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.